| PERIOD ENDING | 5-Mar-09 | 4-Dec-08 | 28-Aug-08 | 29-May-08 | | Total Revenue | 993,000 | 1,402,000 | 1,449,000 | 1,498,000 | | Cost of Revenue | 1,260,000 | 1,851,000 | 1,514,000 | 1,450,000 | | | Gross Profit | (267,000) | (449,000) | (65,000) | 48,000 | | | Operating Expenses | | Research Development | 168,000 | 178,000 | 167,000 | 170,000 | | Selling General and Administrative | 110,000 | 111,000 | 107,000 | 116,000 | | Non Recurring | 163,000 | (66,000) | (1,000) | (13,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (708,000) | (672,000) | (338,000) | (225,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | (4,000) | 5,000 | 15,000 | | Earnings Before Interest And Taxes | (702,000) | (676,000) | (333,000) | (210,000) | | Interest Expense | 35,000 | 30,000 | 20,000 | 21,000 | | Income Before Tax | (737,000) | (706,000) | (353,000) | (231,000) | | Income Tax Expense | 30,000 | (13,000) | 2,000 | 13,000 | | Minority Interest | 77,000 | (13,000) | 11,000 | 8,000 | | | | Net Income From Continuing Ops | (751,000) | (706,000) | (344,000) | (236,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (751,000) | (706,000) | (344,000) | (236,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($751,000) | ($706,000) | ($344,000) | ($236,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
